Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Review the current valuation for Quest Diagnostics Inc (DGX:XNYS) stock based on a yearly calendar providing PE ratios, cash flow, EBITDA and other company valuation information.

The healthcare claims management market is expected to expand at a CAGR of ~5% during the forecast period. Key growth drivers ...

Learn about the executive team and board of directors at Quest Diagnostics Inc (DGX:XNYS) and review their bios and compensation over the latest fiscal years.

Q2 2025 Earnings Call Transcript July 30, 2025 Blackbaud, Inc. beats earnings expectations. Reported EPS is $1.21, ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Detailed price information for Thermo Fisher Scientific Inc (TMO-N) from The Globe and Mail including charting and trades.

Groundbreaking Insights into Neurodegenerative Disease Biomarkers to be Unveiled through 30+ Posters and Presentations at ...

Groundbreaking Insights into Neurodegenerative Disease Biomarkers to be Unveiled through 30+ Posters and Presentations at International Meeting FREMONT, Calif., July 28, 2025 /PRNewswire/ ...

Executives at the laboratory companies said they expect the effects on testing services from the Republicans’ tax and ...